EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $1.40 | N/A |
Market Cap | $108.95M | N/A |
Shares Outstanding | 77.71M | 3.35% |
Employees | 0 | N/A |
Shareholder Equity | 5.12M | -27.77% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -28.15 | N/A |
P/B Ratio | 21.30 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.5125 | N/A |
Earnings | 2023 | Change |
---|---|---|
Earnings | -$2.62M | N/A |
EPS | -0.0498 | N/A |
Earnings Yield | -0.0355 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $7.80M | N/A |
Total Debt | $2.06M | N/A |
Cash on Hand | $6.75M | N/A |
Debt to Equity | 0.8477 | 521.73% |
Cash to Debt | $3.28 | -64.42% |
Current Ratio | $1.70 | -79.52% |